Beta-blockers expand treatment options for infantile hemangiomas
VANCOUVER, B.C. – Propranolol may have revolutionized the treatment of infantile hemangiomas over the past decade, but other beta-blockers are making inroads in the treatment of these and other pediatric dermatologic disorders.
One such beta-blocker is atenolol, a hydrophilic cardioselective agent...googletag.display('div-gpt-ad-cta');
Source: Skin and Allergy News - Category: Dermatology Tags: PED News PED Dermatology SAN Expert Analysis SAN Clinical News SAN News SAN Lasers and Treatment Modalities SAN Pediatric Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Atenolol | Beta-Blockers | Cardiology | Dermatology | Heart | Hemangioma | Inderal | Pediatrics | Skin